Clinical Trial Update: Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections [NA]

View source ↗

Summary

A clinical trial evaluating hydrochloric acid lock therapy for Central Line-associated Bloodstream Infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Line-associated Bloodstream Infection

Drugs mentioned

• Hydrochloric acid lock therapy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Central Line-associated Bloodstream Infection (CLABSI) | NA | Status: COMPLETED